Hsu‐Shan Huang

2.8k total citations
126 papers, 2.4k citations indexed

About

Hsu‐Shan Huang is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Hsu‐Shan Huang has authored 126 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 31 papers in Organic Chemistry and 29 papers in Toxicology. Recurrent topics in Hsu‐Shan Huang's work include Bioactive Compounds and Antitumor Agents (29 papers), Cancer therapeutics and mechanisms (24 papers) and Synthesis and biological activity (20 papers). Hsu‐Shan Huang is often cited by papers focused on Bioactive Compounds and Antitumor Agents (29 papers), Cancer therapeutics and mechanisms (24 papers) and Synthesis and biological activity (20 papers). Hsu‐Shan Huang collaborates with scholars based in Taiwan, United States and Japan. Hsu‐Shan Huang's co-authors include J. David Van Horn, Tsung‐Chih Chen, Chia-Chung Lee, Chun‐Liang Chen, Jing‐Jer Lin, Alexander T.H. Wu, Kuo-Feng Huang, Deh‐Ming Chang, Hui‐Fen Chiu and Ahmed Ali and has published in prestigious journals such as PLoS ONE, Scientific Reports and Coordination Chemistry Reviews.

In The Last Decade

Hsu‐Shan Huang

123 papers receiving 2.4k citations

Peers

Countries citing papers authored by Hsu‐Shan Huang

Since Specialization

Citations

This map shows the geographic impact of Hsu‐Shan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu‐Shan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu‐Shan Huang more than expected).

Fields of papers citing papers by Hsu‐Shan Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsu‐Shan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu‐Shan Huang. The network helps show where Hsu‐Shan Huang may publish in the future.

Co-authorship network of co-authors of Hsu‐Shan Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hsu‐Shan Huang. A scholar is included among the top collaborators of Hsu‐Shan Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsu‐Shan Huang. Hsu‐Shan Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats 2024 ·Biomedicine & Pharmacotherapy ·(unknown), Yu-Cheng Kuo, (unknown), Bashir Lawal, (unknown), (unknown), Adewale Oluwaseun Fadaka, Femi Olawale, Sunday Amos Onikanni, (unknown), Michel De Waard, Dalia Fouad, Gaber El‐Saber Batiha, Saheed Sabiu, Alexander T.H. Wu, Hsu‐Shan Huang	3
2	LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells 2021 ·Journal of Inflammation Research ·Ramcharan Singh Angom, Jian Zhu, Alexander T.H. Wu, (unknown), Victoria C. Pham, Shamit K. Dutta, Enfeng Wang, Vijay Sagar Madamsetty, (unknown), Hsu‐Shan Huang, Debabrata Mukhopadhyay, Ying Wang	3
3	mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications 2021 ·Frontiers in Oncology ·Bashir Lawal, Ching‐Yu Lee, Ntlotlang Mokgautsi, (unknown), (unknown), Alexander T.H. Wu, Hsu‐Shan Huang	50
4	TDAG8 deficiency reduces satellite glial number and pro-inflammatory macrophage number to relieve rheumatoid arthritis disease severity and chronic pain 2020 ·Journal of Neuroinflammation ·(unknown), (unknown), (unknown), (unknown), Hsu‐Shan Huang, (unknown), Shir‐Ly Huang, Wei‐Hsin Sun	25
5	Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression 2020 ·Molecular Biology Reports ·(unknown), (unknown), Hao Chiang, Hsu‐Shan Huang, Wei‐Hsin Sun	36
6	A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway 2019 ·Molecular Cancer Therapeutics ·Chia‐Ling Hsieh, Hsu‐Shan Huang, Kuan‐Chou Chen, (unknown), (unknown), Leland W.K. Chung, Shian‐Ying Sung	24
7	Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma 2019 ·Bioconjugate Chemistry ·Vijay Sagar Madamsetty, Krishnendu Pal, Shamit K. Dutta, Enfeng Wang, James Thompson, Rintu Banerjee‬‬‬‬‬‬‬‬‬, Thomas R. Caulfield, Kabir Mody, Yun Yen, Debabrata Mukhopadhyay, Hsu‐Shan Huang	16
8	Selective recognition and stabilization of new ligands targeting the potassium form of the human telomeric G-quadruplex DNA 2016 ·Scientific Reports ·(unknown), Show‐Mei Chuang, (unknown), Chun‐Liang Chen, Sivakamavalli Jeyachandran, (unknown), Hsu‐Shan Huang, Ming‐Hon Hou	20
9	TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells 2016 ·Cell Death and Disease ·(unknown), Tsung‐Chih Chen, Hsu‐Shan Huang, H. Lee	33
10	Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents 2013 ·European Journal of Medicinal Chemistry ·Tsung‐Chih Chen, Dah‐Shyong Yü, Kuo-Feng Huang, (unknown), Chia-Chung Lee, Chun‐Liang Chen, (unknown), (unknown), Jing‐Jer Lin, Hsu‐Shan Huang	23
11	B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells 2011 ·Anti-Cancer Drugs ·Meng‐Hsuan Cheng, Yu‐Chiao Yang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hsu‐Shan Huang, (unknown), Ming‐Shyan Huang, Hui‐Fen Chiu	15
12	Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury 2011 ·BioMed Research International ·(unknown), Ching-Chih Chang, Hui‐Chun Huang, Yi‐Jen Chen, Ping‐Hsing Tsai, (unknown), Wen‐Hung Chung, (unknown), Hsu‐Shan Huang, Shih‐Hwa Chiou, Fa‐Yauh Lee, Shou‐Dong Lee	13
13	A Concise Paradigm for the Construction of Amide Linker of 2,7-Diamidoanthraquinone Derivatives as Potential Telomerase Inhibitors 2007 ·Zhōnghuá yàoxué zázhì ·Hsu‐Shan Huang, Jing‐Jer Lin, (unknown), (unknown)	2
14	Second Generation Drugs-derivatives of Natural Antitumor Anthracycline Antibiotics Daunorubicin, Doxorubicin and Carminomycin 2006 ·Journal of the Medical Sciences (Berkala Ilmu Kedokteran) ·M. N. Preobrazhenskaya, Anna N. Tevyashova, Eugenia N. Olsufyeva, (unknown), Hsu‐Shan Huang	12
15	Antitumor Anthraquinone Analogues for Multidrug Resistant Tumor Cells 2006 ·Journal of the Medical Sciences (Berkala Ilmu Kedokteran) ·M. N. Preobrazhenskaya, Andrey E. Shchekotikhin, Аlexander А. Shtil, Hsu‐Shan Huang	7
16	Improving Phytase Expression by Increasing the Gene Copy Number of appA-m in Pichia pastoris 2006 ·Chinese journal of biotechnology/Shengwu gongcheng xuebao ·Huiying Luo, Hsu‐Shan Huang, Yingguo Bai, Yajing Wang, Peng Yang, Kun Meng, Tiezheng Yuan, Bing Yao	17
17	Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones 2005 ·Bioorganic & Medicinal Chemistry ·Hsu‐Shan Huang, (unknown), (unknown), (unknown), (unknown), (unknown), Jing‐Jer Lin	33
18	Chromophore-Modified Antitumor Anthracenes. 1. Cytotoxic Activity of 9-Acyloxy 1,5-Dichloroanthracene Analogues 2001 ·Zhōnghuá yàoxué zázhì ·Hsu‐Shan Huang, Jing‐Min Hwang, Yee‐Min Jen, Chi‐Wei Tao, (unknown), (unknown)	2
19	Development of novel antipsoriatic anthrones 1996 ·Zhōnghuá yàoxué zázhì ·Klaus Müller, Hsu‐Shan Huang	1
20	Summary of national guidelines for diagnosis and management of lipid disorders in Taiwan 1995 ·Zhōnghuá mínguó xīnzàngxué huì zázhì ·Yu‐An Ding, Benjamin N. Chiang, (unknown), Mau‐Song Chang, (unknown), (unknown), (unknown), Ming‐Tsai Chiang, (unknown), Nain‐Feng Chu, Martin M.-T. Fuh, (unknown), Low Tone Ho, (unknown), (unknown), Hsu‐Shan Huang, Po‐Chao Huang, Chii Jeng, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact